Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial von Hannawi, Suad, Wu, Xiao-Hong, Villalobos, Ralph Elvi, Burhan, Erlina, Lallaine Borra, Ma. Dovie, Gupta, Rakesh Kumar, Aquitania, Grace P., Ang, Blake Warren C., Mae A. Zabat, Gelza, Roa, Camilo C., Zoleta-De Jesus, Loreta, Yu, Dan-Dan, Wang, Meng, Wu, Yan, Song, Wen-Jie, Ying, Bo, Qin, Cheng-Feng

Volltext